Literature DB >> 6794710

Nicotine intake by snuff users.

M A Russell, M J Jarvis, G Devitt, C Feyerabend.   

Abstract

Blood nicotine and cotinine concentrations were measured in 27 volunteers before and after taking snuff. Within 10 minutes after snuffing blood nicotine concentrations were comparable to those obtained after the 10 minutes or so that it takes to smoke a cigarette. Nicotine intake from snuffing was related to the experience of the snuffer. In daily and occasional snuffers increases in plasma nicotine concentrations averaged 77.7 and 12.3 nmol/l (12.6 and 2.0 ng/ml) respectively, while the novices showed no appreciable increase. The increase shown by thea daily snuffers was comparable to the average increase of 62.3 nmol/l (10.1 ng/ml) obtained from a single cigarette by a group of heavy smokers. The peak nicotine concentrations in the daily snuffers were also similar to the peak values in 136 heavy smokers--222.6 and 226-3 nmol/l (36.1 and 36.7 ng/ml), respectively. Unusual multiple-dose snuffing produced massive increases in plasma nicotine to concentrations that have never been recorded in smokers. The similarity of the concentrations produced by regular daily snuffing and regular daily smoking suggests that the plasma nicotine concentration has some controlling influence over the self-regulation of these two quite different forms of tobacco use. The rapid absorption of nicotine from snuff confirms its potential as an acceptable and relatively harmless substitute for smoking.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6794710      PMCID: PMC1507093          DOI: 10.1136/bmj.283.6295.814

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  11 in total

1.  The absorption of nicotine from tobacco snuff through the nasal mucosa.

Authors:  D J Temple
Journal:  Arch Pharm (Weinheim)       Date:  1976-12       Impact factor: 3.751

2.  A study of tobacco carcinogenesis. XIV. Effects of N'-nitrosonornicotine and N'-nitrosonanabasine in rats.

Authors:  D Hoffmann; R Raineri; S S Hecht; R Maronpot; E L Wynder
Journal:  J Natl Cancer Inst       Date:  1975-10       Impact factor: 13.506

3.  Snuff-dipper's lesion. A cytological and pathological study in a large population.

Authors:  J F Smith; H A Mincer; K P Hopkins; J Bell
Journal:  Arch Otolaryngol       Date:  1970-11

4.  A new age for snuff?

Authors:  M A Russell; M J Jarvis; C Feyerabend
Journal:  Lancet       Date:  1980-03-01       Impact factor: 79.321

5.  Assay of nicotine in biological materials: sources of contamination and their elimination.

Authors:  C Feyerabend; M A Russell
Journal:  J Pharm Pharmacol       Date:  1980-03       Impact factor: 3.765

6.  Blood nicotine and carboxyhemoglobin levels after rapid-smoking aversion therapy.

Authors:  M A Russell; M Raw; C Taylor; C Feyerabend; Y Saloojee
Journal:  J Consult Clin Psychol       Date:  1978-12

7.  Rapid gas-liquid chromatographic determination of cotinine in biological fluids.

Authors:  C Feyerabend; M A Russell
Journal:  Analyst       Date:  1980-10       Impact factor: 4.616

8.  Expired air carbon monoxide: a simple breath test of tobacco smoke intake.

Authors:  M J Jarvis; M A Russell; Y Saloojee
Journal:  Br Med J       Date:  1980-08-16

9.  Geographic patterns of oral cancer in the United States: etilogic implications.

Authors:  W J Blot; J F Fraumeni
Journal:  J Chronic Dis       Date:  1977-11

10.  Snuff dipping and oral cancer among women in the southern United States.

Authors:  D M Winn; W J Blot; C M Shy; L W Pickle; A Toledo; J F Fraumeni
Journal:  N Engl J Med       Date:  1981-03-26       Impact factor: 91.245

View more
  26 in total

1.  Nasal nicotine spray: a rapid nicotine delivery system.

Authors:  G Sutherland; M A Russell; J Stapleton; C Feyerabend; O Ferno
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 2.  Health consequences of using smokeless tobacco: summary of the Advisory Committee's report to the Surgeon General.

Authors:  J W Cullen; W Blot; J Henningfield; G Boyd; R Mecklenburg; M M Massey
Journal:  Public Health Rep       Date:  1986 Jul-Aug       Impact factor: 2.792

3.  Prevalence of alternative forms of tobacco use in a population of young adult military recruits.

Authors:  Mark W Vander Weg; Alan L Peterson; Jon O Ebbert; Margaret Debon; Robert C Klesges; C Keith Haddock
Journal:  Addict Behav       Date:  2007-07-13       Impact factor: 3.913

Review 4.  Clinical pharmacokinetics of nasal nicotine delivery. A review and comparison to other nicotine systems.

Authors:  N G Schneider; E Lunell; R E Olmstead; K O Fagerström
Journal:  Clin Pharmacokinet       Date:  1996-07       Impact factor: 6.447

5.  An in-depth analysis of male adolescent smokeless tobacco users: interviews with users and their fathers.

Authors:  D V Ary; E Lichtenstein; H Severson; W Weissman; J R Seeley
Journal:  J Behav Med       Date:  1989-10

6.  Self-titration by experienced e-cigarette users: blood nicotine delivery and subjective effects.

Authors:  Lynne E Dawkins; Catherine F Kimber; Mira Doig; Colin Feyerabend; Olivia Corcoran
Journal:  Psychopharmacology (Berl)       Date:  2016-05-27       Impact factor: 4.530

7.  Overreporting of smokeless tobacco use by adolescent males.

Authors:  S J Cohen; B P Katz; C A Drook; A G Christen; J L McDonald; B L Olson; L A Cloys; G K Stookey
Journal:  J Behav Med       Date:  1988-08

Review 8.  The nicotine inhaler: clinical pharmacokinetics and comparison with other nicotine treatments.

Authors:  N G Schneider; R E Olmstead; M A Franzon; E Lunell
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

9.  Knowledge, intent to use, and use of smokeless tobacco among sixth grade schoolchildren in six selected U.S. sites.

Authors:  C L Backinger; B Bruerd; M B Kinney; S M Szpunar
Journal:  Public Health Rep       Date:  1993 Sep-Oct       Impact factor: 2.792

Review 10.  Chemical analyses as validators in smoking cessation programs.

Authors:  D D Gilbert
Journal:  J Behav Med       Date:  1993-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.